Description

3-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)Propanoic Acid is a high-purity xanthine derivative, serving as a critical advanced pharmaceutical intermediate. Its molecular structure makes it a valuable building block for the synthesis of novel therapeutic agents, particularly in the development of adenosine receptor antagonists. This compound is essential for research and development laboratories, pharmaceutical manufacturers, and fine chemical producers focused on creating next-generation cardiovascular and neurological drugs.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of potent and selective adenosine A1 and A2A receptor antagonists.
• Research Chemical: Used in biochemical research to study purinergic signaling pathways and receptor-ligand interactions.
• Drug Discovery: Serves as a core scaffold for medicinal chemistry programs aimed at developing treatments for Parkinson's disease, asthma, and cardiac ischemia.
• Fine Chemical Synthesis: Building block for creating complex molecules with potential anti-inflammatory and neuroprotective properties.
• Reference Standard: Used as an analytical standard in quality control laboratories for method development and validation.

Basic Information

Product Name	3-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)Propanoic Acid
CAS No.	17781-08-7
Molecular Formula	C12H14N4O4
Molecular Weight	278.26 g/mol
Synonyms	7-(2-Carboxyethyl)-1,3-dimethylxanthine; 1,3-Dimethyl-7-(2-carboxyethyl)xanthine; Xanthinol Nicotinate Impurity; Xanthinol Nicotinate Related Compound A; 3-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)propanoic acid; 7-(2-Carboxyethyl)theophylline; 1,3-Dimethyl-7-(β-carboxyethyl)xanthine
EINECS	Contact for details

Quality Control

Our 3-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)Propanoic Acid is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical intermediate use. Certificates of Analysis (COA) with full traceability are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from strong oxidizing agents and bases.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.